Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issa Ismail Issa

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myelomaIssa Ismail Issa, Rasmus Froberg Brøndum, Hanne Due, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2022
Hsp90 inhibition sensitizes DLBCL cells to cisplatinLinnéa Schmidt, Issa Ismail Issa, Hulda Haraldsdóttir, et al.
Cancers|July 13, 2024
CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and <i>BTK</i> as Essential for Cisplatin Response in Diffuse Large B-Cell LymphomaIssa Ismail Issa, Hanne Due, Rasmus Froberg Brøndum, et al.
International Journal of Molecular Sciences|June 26, 2025
Overexpression of <i>CDCA2</i> in Diffuse Large B-Cell Lymphoma Promotes Cell Proliferation and Bortezomib SensitivityHanne Due, Asta Brogaard, Issa Ismail Issa, et al.
American Journal of Medical Genetics. Part A|December 3, 2025
Case Series: Clinical Significance of Heterozygous Pathogenic RTEL1 Variants Identified via Routine Clinical Genetic DiagnosticsEileen Wedge, Andreas Ørslev Rasmussen, Line Borgwardt, et al.
Human Mutation|June 29, 2026
Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based MethodNikolaj Juul Nitschke, Marwa Almosailleakh, Issa Ismail Issa, et al.
American Journal of Hematology|November 16, 2024
High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeuticsWaseem Lone, Alyssa Bouska, Tyler A Herek, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myelomaIssa Ismail Issa, Rasmus Froberg Brøndum, Hanne Due, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2022
Hsp90 inhibition sensitizes DLBCL cells to cisplatinLinnéa Schmidt, Issa Ismail Issa, Hulda Haraldsdóttir, et al.
Cancers|July 13, 2024
CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and <i>BTK</i> as Essential for Cisplatin Response in Diffuse Large B-Cell LymphomaIssa Ismail Issa, Hanne Due, Rasmus Froberg Brøndum, et al.
International Journal of Molecular Sciences|June 26, 2025
Overexpression of <i>CDCA2</i> in Diffuse Large B-Cell Lymphoma Promotes Cell Proliferation and Bortezomib SensitivityHanne Due, Asta Brogaard, Issa Ismail Issa, et al.
American Journal of Medical Genetics. Part A|December 3, 2025
Case Series: Clinical Significance of Heterozygous Pathogenic RTEL1 Variants Identified via Routine Clinical Genetic DiagnosticsEileen Wedge, Andreas Ørslev Rasmussen, Line Borgwardt, et al.
Human Mutation|June 29, 2026
Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based MethodNikolaj Juul Nitschke, Marwa Almosailleakh, Issa Ismail Issa, et al.
American Journal of Hematology|November 16, 2024
High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeuticsWaseem Lone, Alyssa Bouska, Tyler A Herek, et al.
Pageof 1